BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 35300506)

  • 1. A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial.
    Esmaeilzadeh H; Far NM; Nabavizadeh SH; Babaeian M; Hadipour M; Alyasin S
    Am J Rhinol Allergy; 2022 Sep; 36(5):559-567. PubMed ID: 35300506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
    Berger WE; Fineman SM; Lieberman P; Miles RM
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score.
    Sardana N; Santos C; Lehman E; Craig T
    Allergy Asthma Proc; 2010; 31(1):5-9. PubMed ID: 20167140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Montelukast in Allergic Rhinitis Treatment: A Systematic Review and Meta-Analysis.
    Krishnamoorthy M; Mohd Noor N; Mat Lazim N; Abdullah B
    Drugs; 2020 Nov; 80(17):1831-1851. PubMed ID: 32915441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis.
    Feng S; Fan Y; Liang Z; Ma R; Cao W
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3477-3486. PubMed ID: 26545381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal antihistamine is superior to oral H
    Du K; Qing H; Zheng M; Wang X; Zhang L
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
    Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
    Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine.
    Stern MA; Wade AG; Ridout SM; Cambell LM
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):354-8. PubMed ID: 9809500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE; Meltzer EO
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of childhood epistaxis with treatment of allergic rhinitis: a randomized controlled study.
    Teo WY; Wong HB; Hwarng GYH; Tan HKK
    Eur J Pediatr; 2023 Mar; 182(3):1127-1135. PubMed ID: 36595087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial.
    Mahatme MS; Dakhale GN; Tadke K; Hiware SK; Dudhgaonkar SD; Wankhede S
    Indian J Pharmacol; 2016; 48(6):649-653. PubMed ID: 28066101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis].
    Jia MH; Chen XY; Zhang Y; Liao ZS
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):369-373. PubMed ID: 29871264
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
    Davies RJ; Lund VJ; Harten-Ash VJ
    Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W; Wiseman LR
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
    Kim MK; Lee SY; Park HS; Yoon HJ; Kim SH; Cho YJ; Yoo KH; Lee SK; Kim HK; Park JW; Park HW; Chung JH; Choi BW; Lee BJ; Chang YS; Jo EJ; Lee SY; Cho YS; Jee YK; Lee JM; Jung J; Park CS
    Clin Ther; 2018 Jul; 40(7):1096-1107.e1. PubMed ID: 29945738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
    Goh BS; Ismail MI; Husain S
    J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.